Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib

Completed · Phase 4

Conditions studied: Pain

In brief

This study will assess the safety and efficacy of lumiracoxib 400 mg in relieving moderate to severe post-dental surgery pain, compared to both placebo and celecoxib 400 mg.

Key facts

Study ID

NCT00348491

Run by

Novartis Pharmaceuticals

People needed

364

Starts

2006-02-01

Last updated by the study team

2017-02-23

Who can join

Age: 17 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Requiring extraction of two or more partially impacted or fully bony impacted third molars. At least one of the extractions must be mandibular
• Moderate to severe post-dental surgery pain intensity (as rated by the patient on the categorical pain intensity scale within five hours of surgery

You may not qualify if…

• Evidence or history of any cardiac and cerebral thrombotic/ ischemic diseases and/ or events
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Dental Research Clinic — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.